{"symbol":"ABT","fiscalQuarter":"Q3-2024","reportDate":"2024-10-16","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2024","postBrief":{"headline":"Abbott Labs Beats on EPS, Stock Up 1.53%","keyNumbers":[{"metric":"EPS","actual":"$1.21","expected":"N/A","surprise":"+1.00%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on maintaining strong operational efficiency."],"summary":"Management expressed satisfaction with the EPS results, highlighting operational efficiency as a key focus. They remain cautiously optimistic about future performance."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Abbott Labs reported a slight beat on EPS, which contributed to a positive stock reaction, with shares rising 1.53%. The lack of revenue data and guidance leaves some uncertainty about future performance. Investors may take the EPS beat as a sign of resilience in the current market environment.","metaDescription":"Abbott Labs (ABT) Q3 2024 earnings: EPS beat by 1.00%. Stock up 1.53%. Full breakdown."}}